메뉴 건너뛰기




Volumn 55, Issue JULY, 2007, Pages 507-510

Clinical applications of molecular haematology: JAK2 in myeloproliferative disorders

Author keywords

[No Author keywords available]

Indexed keywords

JAK2 PROTEIN, HUMAN; JANUS KINASE 2; UNCLASSIFIED DRUG;

EID: 34347404121     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (1)

References (12)
  • 1
    • 0001639195 scopus 로고
    • Some speculations on the myeloproliferative syndromes
    • Damashek W. Some speculations on the myeloproliferative syndromes. Blood 1951;6:372-5.
    • (1951) Blood , vol.6 , pp. 372-375
    • Damashek, W.1
  • 2
    • 32144453842 scopus 로고    scopus 로고
    • JAK/STAT signal transduction : Regulators and implication in haematological malignancies
    • Valentino L, Pierre J. JAK/STAT signal transduction : regulators and implication in haematological malignancies. Biochemical Pharmacology 2006;71:713-21.
    • (2006) Biochemical Pharmacology , vol.71 , pp. 713-721
    • Valentino, L.1    Pierre, J.2
  • 3
    • 33746043322 scopus 로고    scopus 로고
    • The role of Janus kinases in haemopoiesis and haematological malignancy
    • Khwaja A. The role of Janus kinases in haemopoiesis and haematological malignancy. Br J Haematol 2006;134:366-84.
    • (2006) Br J Haematol , vol.134 , pp. 366-384
    • Khwaja, A.1
  • 4
    • 0020972981 scopus 로고
    • Translocation of c-abl oncogene correlates with the presence of the Philadelphia chromosome in chronic myelocytic leukaemia
    • Bartram C, de Klein A, Hagemeijer A. Translocation of c-abl oncogene correlates with the presence of the Philadelphia chromosome in chronic myelocytic leukaemia. Nature 1983;306:277-280.
    • (1983) Nature , vol.306 , pp. 277-280
    • Bartram, C.1    de Klein, A.2    Hagemeijer, A.3
  • 5
    • 20144363192 scopus 로고    scopus 로고
    • Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
    • Baxter EJ, Scott LM, Camphell PJ, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005;365:1054-61.
    • (2005) Lancet , vol.365 , pp. 1054-1061
    • Baxter, E.J.1    Scott, L.M.2    Camphell, P.J.3
  • 6
    • 17844383458 scopus 로고    scopus 로고
    • A unique clonal JAK2 mutations leading to constitutive signaling causes polycythemia vera
    • James C, Ugo V, Le Couedic, et al. A unique clonal JAK2 mutations leading to constitutive signaling causes polycythemia vera. Nature 2005;434:1144-8.
    • (2005) Nature , vol.434 , pp. 1144-1148
    • James, C.1    Ugo, V.2    Couedic, L.3
  • 7
    • 17644424955 scopus 로고    scopus 로고
    • A gain-of-functions mutation of JAK2 is myeloproliferative disorders
    • Kralovics R, Passamonti F, Buser AS et al. A gain-of-functions mutation of JAK2 is myeloproliferative disorders. N Eng J Med 2005;352:1779-90.
    • (2005) N Eng J Med , vol.352 , pp. 1779-1790
    • Kralovics, R.1    Passamonti, F.2    Buser, A.S.3
  • 8
    • 20244369569 scopus 로고    scopus 로고
    • Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia and myeloid metaplasia with myelofibrosis
    • Levine RL, Wedleigh M, et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia and myeloid metaplasia with myelofibrosis. Cancer Cell 2005;7:387-97.
    • (2005) Cancer Cell , vol.7 , pp. 387-397
    • Levine, R.L.1    Wedleigh, M.2
  • 9
    • 20744460045 scopus 로고    scopus 로고
    • identification of an acquired JAK2 mutation in polycythemia vera
    • Zhao R, Xing S, et al. identification of an acquired JAK2 mutation in polycythemia vera. Journal of Biol Chem 2005;280:22788-92.
    • (2005) Journal of Biol Chem , vol.280 , pp. 22788-22792
    • Zhao, R.1    Xing, S.2
  • 10
    • 34347401112 scopus 로고    scopus 로고
    • V617F mutation in familial myeloproliferative disorders. Program and abstracts of the 2005 American Society of Haematology Annual Meeting and Exposition : December 10-13, 2005; Atlanta, Georgia. Abstract 115.
    • V617F mutation in familial myeloproliferative disorders. Program and abstracts of the 2005 American Society of Haematology Annual Meeting and Exposition : December 10-13, 2005; Atlanta, Georgia. Abstract 115.
  • 11
    • 34047236618 scopus 로고    scopus 로고
    • Markers of myeloproliferative disease in childhood polycythemia vera and essential thrombocythemia
    • Teofili L, Giona F, et al. Markers of myeloproliferative disease in childhood polycythemia vera and essential thrombocythemia. J Clin Oncol 2007;25:1048-53.
    • (2007) J Clin Oncol , vol.25 , pp. 1048-1053
    • Teofili, L.1    Giona, F.2
  • 12
    • 33947541141 scopus 로고    scopus 로고
    • V617F activity and polycythemia vera cell growth
    • V617F activity and polycythemia vera cell growth. J Biol Chem 2007;282:3428-34.
    • (2007) J Biol Chem , vol.282 , pp. 3428-3434
    • Li, Z.1    Xu, N.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.